ORTHOCON, INC.

Abyrx, Inc. is a biosurgical company based in Stamford, Connecticut that develops and manufactures therapeutic devices and solutions focused on surgical hemostasis and bone defect treatment. The company leverages a proprietary polymer-based materials science platform to create hemostatic bone putties and resorbable biomaterials designed for use in orthopedic, trauma, spine, cardiothoracic, and maxillofacial surgical procedures. With over 450,000 product uses across more than 1,000 U.S. hospitals and cumulative revenues exceeding $100 million, Abyrx has established itself as a significant player in the surgical hemostasis market. The company's product portfolio includes the Hemasorb® family of hemostatic bone putties, the MONTAGE® settable bone putty, and Permatage® adhesive products. All offerings emphasize ease of preparation and application in the operating room. Abyrx also operates KAIRUKU, a proprietary SaaS platform that supports hospital inventory tracking and case management.